AAV Empty Capsids: For Better or for Worse?-Reference-Cited by-同舟云学术

AAV Empty Capsids: For Better or for Worse?

Published:2014-01 Issue:1 Volume:22 Page:1-2
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Wright J Fraser

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference6 articles.

1. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B;Nathwani;N Engl J Medicine,2011

2. Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial;Allay;Hum Gene Ther,2011

3. Overcoming preexisting humoral immunity to AAV using capsid decoys;Mingozzi;Science Transl Med,2013

4. Covert warfare against the immune system: decoy capsids, stealth genomes, and suppressors;Hoffman;Mol Ther,2013

5. Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects;Gao;Mol Ther Methods Clin Dev,2013

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational downstream development for adeno-associated virus full/empty capsid separation – A streamlined methodology based on high-throughput screening and mechanistic modeling;Journal of Chromatography A;2024-02

2. Adeno-associated viral capsid stability on anion exchange chromatography column and its impact on empty and full capsid separation;Molecular Therapy - Methods & Clinical Development;2023-12

3. A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodies;Molecular Therapy - Methods & Clinical Development;2023-12

4. Prospective approaches to gene therapy computational modeling – spotlight on viral gene therapy;Journal of Pharmacokinetics and Pharmacodynamics;2023-10-17

5. Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells;Human Gene Therapy;2023-10-01